Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
38.99
-0.78 (-1.96%)
At close: Sep 21, 2026, 4:00 PM EDT
39.13
+0.14 (0.36%)
After-hours: Sep 21, 2026, 4:04 PM EDT
Roivant Sciences Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Roivant Sciences stock has a consensus rating of "Strong Buy" and an average price target of $46.86. The average 1-year stock price forecast is 20.18% higher than the current stock price, while the lowest is $37.5 (-3.82%) and the highest is $55 (+41.06%).
Price Target: $46.86 (+20.18%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Roivant Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 9 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 18, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Initiates $51 | Buy | Initiates | $51 | +30.80% | Sep 16, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $42 → $52 | Buy | Maintains | $42 → $52 | +33.37% | Sep 16, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $42 → $46 | Buy | Reiterates | $42 → $46 | +17.98% | Sep 9, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $50 → $55 | Buy | Reiterates | $50 → $55 | +41.06% | Sep 8, 2026 |
Financial Forecast
Revenue This Year
52.84M
from 8.26M
Increased by 539.74%
Revenue Next Year
409.67M
from 52.84M
Increased by 675.27%
EPS This Year
-1.58
from -1.08
EPS Next Year
-1.72
from -1.58
EPS and Forward PE are based on non-GAAP adjusted numbers.